This Amer Sports Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Analysts initiate: Buy—Abivax ($155), Amer Sports ($42) and more
Stocks · News reference
Caleres Posts Upbeat Q2 Earnings, Joins Opus Genetics, Flotek Industries And Other Big Stocks Moving Higher On Wednesday
U.S. stocks fell, but Caleres surged 14% on strong results and higher guidance. Opus Genetics, Signet and Oddity also posted big gains.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Oppenheimer Initiates Coverage On Aehr Test System with Outperform Rating, Announces Price Target of $120
Oppenheimer analyst Edward Yang initiates coverage on Aehr Test System (NASDAQ:AEHR) with a Outperform rating and announces Price Target of $120.
Roivant Sciences, Pharvaris, IonQ And Other Big Stocks Moving Higher On Tuesday
U.S. stocks fell Tuesday, but Roivant surged 16% on positive PH-ILD trial data. Pharvaris, Solaris, IonQ and quantum stocks also posted strong gains.
Roth Capital Maintains Neutral on Ambarella, Lowers Price Target to $65
Roth Capital analyst Suji Desilva maintains Ambarella (NASDAQ:AMBA) with a Neutral and lowers the price target from $90 to $65.
Stifel Maintains Buy on Ambarella, Lowers Price Target to $90
Stifel analyst Tore Svanberg maintains Ambarella (NASDAQ:AMBA) with a Buy and lowers the price target from $106 to $90.
B of A Securities Maintains Neutral on Ambarella, Lowers Price Target to $70